[General Articles] Altered Protein Acetylation in Polyglutamine Diseases

By  

Current Medicinal Chemistry, Vol. 10, Iss. 23, 2003-12 ,pp. : 2577-2587

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide-Based Therapeutic Approaches for Treatment of the Polyglutamine Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2575-2582

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation

By  

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2543-2555

Bentham Science Publishers

Access to resources Recommend Favorite

Modulatory role of verapamil treatment on the cardiac electrophysiological effects of cisapride

By Morissette Pierre   Hreiche Raymond   Turgeon Jacques  

Canadian Journal of Physiology and Pharmacology, Vol. 84, Iss. 12, 2006-12 ,pp. : 1285-1290

NRC Research Press

Access to resources Recommend Favorite

Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases

By Steffan Joan S   Thompson Leslie Michels  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 201-213

Informa Healthcare

Access to resources Recommend Favorite